Guggenheim Capital’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Guggenheim Capital's VCYT Position: Q2 2026 in Review
Guggenheim Capital increased its Veracyte (VCYT) stake by 6.9% in Q2 2026, buying an estimated $90.4K and bringing the position to 33,505 shares worth $1.97M. The position accounts for 0.01% of the portfolio, ranked #741.
Guggenheim Capital first reported a position in VCYT in Q2 2021 and has held it in 14 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Guggenheim Capital held 33,505 shares of Veracyte worth $1.97M as of Q2 2026.
- Guggenheim Capital bought 2,157 Veracyte shares in Q2 2026, an estimated $90.4K.
- Veracyte made up 0.01% of Guggenheim Capital's portfolio in Q2 2026, its #741 holding.
- Guggenheim Capital first reported a position in Veracyte in Q2 2021 and has held it in 14 quarters since.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.